Concepedia

Sara E. Kost

SE

Statistics

Publications

7

Citations

992

H-Index

7

Active since

2009

Affiliations

University of Manitoba(Current)

BC Cancer Agency

University of British Columbia

University of Victoria

Public Health Agency of Canada

Sara E. Kost is an author at University of Manitoba specializing in life sciences, tumor immunology, and tumor-infiltrating lymphocytes.

Publications per year

2009–2015

7

Publications

7

CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer

Julie S. Nielsen, Rob A. Sahota, Katy Milne et al. · Clinical Cancer Research · 2012 · 547 citations

, , +17

Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer

Nathaniel R. West, Sara E. Kost, Spencer D. Martin et al. · British Journal of Cancer · 2012 · 269 citations · Full text

, , +14

Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007–2009 study

Kimberly A. Nichol, Heather J. Adam, Zafar Hussain et al. · Diagnostic Microbiology and Infectious Disease · 2011 · 65 citations

, , +15

CD25 Identifies a Subset of CD4+FoxP3− TIL That Are Exhausted Yet Prognostically Favorable in Human Ovarian Cancer

Ronald J. deLeeuw, David R. Kroeger, Sara E. Kost et al. · Cancer Immunology Research · 2014 · 44 citations

, , +17

Transcriptome atlas of the Arabidopsis funiculus – a study of maternal seed subregions

Deirdre Khan, Jenna L. Millar, Ian J. Girard et al. · The Plant Journal · 2015 · 36 citations · Full text

, , +17

1–5 of 7